- Oxford Nanopore Technologies
- 06 August 2025 11:58:46
Source: Sharecast
The FTSE 250 biotechnology firm said the lawsuit, filed in the Federal Court of Australia, was part of its commitment to protecting the intellectual property underpinning its nanopore-based molecular sensing platform used in research and applied sciences across the region.
“Oxford Nanopore's decision to commence legal proceedings against MGI has been carefully considered and reflects the company's responsibility to protect the intellectual property that underpins its sensing platform,” the firm said in a statement.
It emphasised that the legal action would not affect its ongoing operations, customers or partners, and that safeguarding its intellectual property remained vital to supporting continued investment in technological innovation.
The company said its patents were granted in key jurisdictions including the US, Europe, and Australia.
At 1137 BST, shares in Oxford Nanopore Technologies were up 0.14% at 217.31p.
Reporting by Josh White for Sharecast.com.